Terumo Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TRUMF | 688016.SS | 300003.SZ | 9996.HK | NOLA-B.ST | 5187.T | |
|---|---|---|---|---|---|---|
| Market cap | 22.69B | 10.96B | 23.19B | 2.65B | 14.09B | 8.84B |
| P/E (TTM) | 21.4 | 18.4 | 34.9 | — | 20.9 | 18.2 |
| Forward P/E | — | 15.0 | 17.5 | 24.1 | 17.8 | — |
| Price/book | 2.2 | 2.5 | 1.4 | 1.2 | 2.4 | 0.5 |
| Dividend yield | 1.48% | 2.98% | 2.60% | — | 3.30% | 4.33% |
| 1-year change | −5.06% | −11.00% | −30.03% | −35.66% | −14.02% | +10.47% |
| Today | 0.00% | +1.76% | +0.56% | +6.31% | +1.55% | +0.27% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All TRUMF news ›Comparing Terumo (OTCMKTS:TRUMY) & Pulmonx (NASDAQ:LUNG)
Posted by Tristan Rich on Nov 2nd, 2026 Terumo (OTCMKTS:TRUMY – Get Free Report) and Pulmonx (NASDAQ:LUNG – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on…
Final Data in International Trial Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil® Embolic System for Treatment of Cerebral Aneurysms
Aug 03, 2010, 10:00 ET The results were presented by the study's chief investigator, Philip White, M.D., of Western General Hospital in Edinburgh, Scotland, at the 7th annual meeting of the Society of Neurointerventional Surgery (SNIS) in…
Terumo Blood and Cell Technologies and Ribeirão Preto Blood Center automate blood processing in Brazil
The work at Ribeirão Preto demonstrates that advanced automation can be adopted in a public blood service when operational needs and long-term resource planning come together.The project also demonstrates the value of innovating blood…
Terumo Corporation (TRUMY) Discusses Technological Capabilities and R&D Strategy for Sustained Competitive Advantage Transcript
Terumo Corporation (TRUMY) Discusses Technological Capabilities and R&D Strategy for Sustained Competitive Advantage October 19, 2026 12:00 AM EDT Hikaru Samejima - Representative Director, President & CEOToshihiko OsadaShinji Omori - CTO,…
Why Did Terumo Acquire Arsenal Medical?
The primary battlefield for the medical device industry, to which Arsenal Medical Inc. belongs, is the neurovascular device and embolic material market. This sector maintains one of the highest growth rates in the medical device industry,…
Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies
Oct 19, 2026, 10:00 ET Automated whole blood processing will expand platelet production capacity and help meet growing hospital demand Platelets are a critical blood component used to support patients undergoing cancer treatment, surgery…
News from Terumo Blood and Cell Technologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
news News from Terumo Blood and Cell Technologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. 10:00…
Terumo announces global commercial launch of K-pack Embrace Active safety needle
Manufacturing Chemist Terumo Corporation (TSE: 4543) today announced the global commercial launch of its K-Pack Embrace Active safety needle. The new safety injection needle is packaged in a rigid cap and case container
More from 1 other outlet
Japan Earnings Wrap: Pan Pacific International, Terumo Decline
Japanese stocks reporting earnings declined on Wednesday, with retailers and thermometer manufacturers leading the laggards. Pan Pacific International Holdings shares tumbled nearly 11% despite... Medical Equipment, Supplies & Distribution…
Latham Advises Arsenal Medical in Acquisition by Terumo Neuro
Terumo Neuro announced it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing NeoCast™, an investigational next-generation liquid embolic technology for the treatment of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- legaldesire.com1
- lw.com1
- manufacturingchemist.com1
- marketscreener.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.